ChristianMMDivenDGSanchezRLSolowayRD.Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. J Am Acad Dermatol1997;37:118–20.
2.
KurzenHPetzoldtDHartschuhWJappeU.Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha. Acta Derm Venereol2002;82:310–2.
3.
PouthierDTheissenFHumbelRL.Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient. Nephrol Dial Transplant2002;17:174.
4.
BessisDCharronARouzier-PanisRBlatiereVGuilhouJJReynesJ.Necrotizing cutaneous lesions complicating treatment with pegylated-in-terferon alfa in an HIV-infected patient. Eur J Dermatol2002;12:99–102.
5.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
